Dancann Pharma A/S logo

DANCAN - Dancann Pharma A/S Share Price

DKK5.24 0.4  9.3%

Last Trade - 06/12/21

Micro Cap
Market Cap £11.4m
Enterprise Value £10.8m
Revenue £n/a
Position in Universe 1584th / 1889
Unlock DANCAN Revenue
Relative Strength (%)
1m +41.7%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.10%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 0.99 14.8
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 September 2021, DancannPharma A/S revenues was not reported. Net loss increasedfrom DKR2.7M to DKR7.3M. Higher net loss reflects PersonnelExpenses increase from DKR427K to DKR4.1M (expense), OtherExternal Expense increase of 97% to DKR5.3M (expense),Depreciation increase from DKR29K to DKR432K (expense).Basic Earnings per Share excluding Extraordinary Itemsdecreased from -DKR0.15 to -DKR0.35.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


DANCAN Revenue Unlock DANCAN Revenue

Net Income

DANCAN Net Income Unlock DANCAN Revenue

Normalised EPS

DANCAN Normalised EPS Unlock DANCAN Revenue

PE Ratio Range

DANCAN PE Ratio Range Unlock DANCAN Revenue

Dividend Yield Range

DANCAN Dividend Yield Range Unlock DANCAN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
DANCAN EPS Forecasts Unlock DANCAN Revenue
Profile Summary

Dancann Pharma A/S is a Denmark-based pharmaceutical biotechnology company powered by cannabinoids. The Company is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas. DanCann Pharma manufactures and distributes prescription drugs (Rx drugs) and over-the-counter drugs (OTCs), mainly focused on pain patients with alternative needs.

Last Annual December 31st, 2020
Last Interim June 30th, 2021
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange AktieTorget Stock Exchange
Shares in Issue 20,730,800
Free Float (0.0%)
Eligible for
View larger map
Address Rugvaenget 5, ANSAGER, 6823, Denmark
Phone +
Auditors BDO Statsautoriseret Revisionsaktieselskab
DANCAN Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for DANCAN
Upcoming Events for DANCAN
Frequently Asked Questions for Dancann Pharma A/S
What is the Dancann Pharma A/S share price?

As of 06/12/21, shares in Dancann Pharma A/S are trading at DKK5.24, giving the company a market capitalisation of £11.4m. This share price information is delayed by 15 minutes.

How has the Dancann Pharma A/S share price performed this year?

Shares in Dancann Pharma A/S are currently trading at DKK5.24 and the price has moved by 40% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Dancann Pharma A/S price has moved by 18.22% over the past year.

What are the analyst and broker recommendations for Dancann Pharma A/S?

There are no analysts currently covering Dancann Pharma A/S.

When will Dancann Pharma A/S next release its financial results?

Dancann Pharma A/S is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-06-30
What is the Dancann Pharma A/S dividend yield?

Dancann Pharma A/S does not currently pay a dividend.

Does Dancann Pharma A/S pay a dividend?

Dancann Pharma A/S does not currently pay a dividend.

When does Dancann Pharma A/S next pay dividends?

Dancann Pharma A/S does not currently pay a dividend.

How do I buy Dancann Pharma A/S shares?

To buy shares in Dancann Pharma A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Dancann Pharma A/S?

Shares in Dancann Pharma A/S are currently trading at DKK5.24, giving the company a market capitalisation of £11.4m.

Where are Dancann Pharma A/S shares listed? Where are Dancann Pharma A/S shares listed?

Here are the trading details for Dancann Pharma A/S:

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: DANCAN
What kind of share is Dancann Pharma A/S?

Based on an overall assessment of its quality, value and momentum, Dancann Pharma A/S is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Dancann Pharma A/S share price forecast 2021?

Shares in Dancann Pharma A/S are currently priced at DKK5.24. At that level they are trading at 46.11% discount to the analyst consensus target price of 0.00.

Analysts covering Dancann Pharma A/S currently have a consensus Earnings Per Share (EPS) forecast of -0.6630539852 for the next financial year.

How can I tell whether the Dancann Pharma A/S share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Dancann Pharma A/S. Over the past six months, the relative strength of its shares against the market has been 22.42%. At the current price of DKK5.24, shares in Dancann Pharma A/S are trading at 29.57% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Dancann Pharma A/S PE Ratio?

We were not able to find PE ratio data for Dancann Pharma A/S.

Who are the key directors of Dancann Pharma A/S?

We were unable to find the directors for Dancann Pharma A/S.

Who are the major shareholders of Dancann Pharma A/S?

Here are the top five shareholders of Dancann Pharma A/S based on the size of their shareholding:

Similar to DANCAN
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.